Respiratory Archives - Pharmaceutical Technology https://www.pharmaceutical-technology.com/sector/therapy-area/respiratory/ The leading site for news and procurement in the pharmaceutical industry Wed, 21 Aug 2024 10:06:22 +0000 en-US hourly 1 https://wordpress.org/?v=6.6.1 https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2022/01/cropped-Pharmaceutical-Technology-Favicon-150x150.png Respiratory Archives - Pharmaceutical Technology https://www.pharmaceutical-technology.com/sector/therapy-area/respiratory/ 32 32 NMPA approves AstraZeneca’s Fasenra for severe asthma https://www.pharmaceutical-technology.com/news/china-astrazeneca-fasenra-asthma/ Wed, 21 Aug 2024 10:06:03 +0000 https://www.pharmaceutical-technology.com/news/china-astrazeneca-fasenra-asthma/ Noumed’s Pharmaceutical Manufacturing Facility, Adelaide, Australia https://www.pharmaceutical-technology.com/projects/noumed-pharmaceutical-manufacturing-facility-adelaide-australia/ Thu, 15 Aug 2024 08:54:13 +0000 https://www.pharmaceutical-technology.com/?post_type=projects&p=326319 Dupixent “addresses current gap” in COPD biologics landscape https://www.pharmaceutical-technology.com/news/dupixent-addresses-current-gap-in-copd-biologics-landscape/ Fri, 05 Jul 2024 12:27:27 +0000 https://www.pharmaceutical-technology.com/news/dupixent-addresses-current-gap-in-copd-biologics-landscape/ Johnson & Johnson gains FDA and EC approvals for TB treatment https://www.pharmaceutical-technology.com/news/johnson-johnson-tb-approvals/ Wed, 03 Jul 2024 09:02:46 +0000 https://www.pharmaceutical-technology.com/news/johnson-johnson-tb-approvals/ Aerovate slashes workforce after failed Phase IIb trial https://www.pharmaceutical-technology.com/news/aerovate-slashes-workforce-after-failed-phase-iib-trial/ Tue, 02 Jul 2024 16:42:13 +0000 https://www.pharmaceutical-technology.com/news/aerovate-slashes-workforce-after-failed-phase-iib-trial/ Verona scores FDA approval for Ohtuvayre as COPD maintenance therapy https://www.pharmaceutical-technology.com/news/verona-scores-fda-approval-for-ohtuvayre-as-copd-maintenance-therapy/ Thu, 27 Jun 2024 15:59:36 +0000 https://www.pharmaceutical-technology.com/news/verona-scores-fda-approval-for-ohtuvaye-as-copd-maintenance-therapy/ Agomab wins FDA orphan drug status for idiopathic pulmonary fibrosis asset https://www.pharmaceutical-technology.com/news/agomab-wins-fda-orphan-drug-status-for-idiopathic-pulmonary-fibrosis-asset/ Fri, 07 Jun 2024 15:54:05 +0000 https://www.pharmaceutical-technology.com/news/agomab-wins-fda-orphan-drug-status-for-idiopathic-pulmonary-fibrosis-asset/ EMA CHMP supports CStone’s sugemalimab for metastatic NSCLC https://www.pharmaceutical-technology.com/news/cstone-sugemalimab-nsclc/ Mon, 03 Jun 2024 08:27:09 +0000 https://www.pharmaceutical-technology.com/news/cstone-sugemalimab-nsclc/ FDA approves Moderna’s RSV vaccine mRESVIA https://www.pharmaceutical-technology.com/news/fda-moderna-rsv-mresvia/ Mon, 03 Jun 2024 08:18:07 +0000 https://www.pharmaceutical-technology.com/news/fda-moderna-rsv-mresvia/ Amgen and AstraZeneca ponder label expansion for Tezspire in COPD https://www.pharmaceutical-technology.com/news/amgen-and-astrazeneca-ponder-label-expansion-for-tezspire-in-copd/ Mon, 20 May 2024 15:06:01 +0000 https://www.pharmaceutical-technology.com/news/amgen-and-astrazeneca-ponder-label-expansion-for-tezspire-in-copd/